Befovacimab, CAS 2156634-62-5

Product Description: Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Maria Elisa Mancuso, et al. Befovacimab, an anti-tissue factor pathway inhibitor antibody: Early termination of the multiple-dose, dose-escalating Phase 2 study due to thrombosis. Haemophilia. 2022 Sep;28(5):702-712. /[2]Jian-Ming Gu, et al. Mechanistic Modeling of the Pharmacodynamic and Pharmacokinetic Relationship of Tissue Factor Pathway Inhibitor-Neutralizing Antibody (BAY 1093884) in Cynomolgus Monkeys. AAPS J. 2017 Jul;19(4):1186-1195.

CAS Number: 2156634-62-5

Molecular Weight: N/A

Research Area: Cardiovascular Disease

Solubility: 10 mM in DMSO

Target: Thrombin

• Artikelnummer: MEXHY-P99465-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99465-5
• Green Labware: Nein
• Verpackungseinheit: 5mg
• Mengeneinheit: STK